TruLeaf medical presents a breakthrough technology which enables a fully percutaneous procedure to replace a faulty valve, with no need to open the patient's chest, yet, in order to make this dramatic change, a paradigm shift is required and a sacred cow is killed. A two step procedure makes transcatheter valve replacement a reality! The crossing profile is low, the procedure is simple, the anchoring is excellent, all hemodynamic problems are solved, and last but not least – valve life expectancy is the best ever.
Prof. Halkin:
“This technology should hopefully make TMVR simple efficacious and reproducible”
Prof. Kornowski:
“This approach will fit a large number of patients, it will offer simplicity to the operator, very stable anchoring, and consistent results”
TruLeaf has performed a successful first-in-human study for tricuspid valve replacement at the end of 2025. We are currently enrolling new patients.
